Antibodies To Il-17 Polypeptides And Therapeutic Uses Thereof

Abstract

The present invention is directed to novel polypeptides having sequence identity with IL-17 and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention. Further provided herein are methods for treating degenerative cartilaginous disorders.


Claims
Owners (US)

Information currently unavailable.

IPC Classifications
Download PDF
Document Preview
Document History
  • Publication: Jul 6, 2010
  • Application: Aug 7, 2008
    US US 18805408 A
  • Priority: Aug 7, 2008
    US US 18805408 A
  • Priority: May 19, 2006
    US US 43655406 A
  • Priority: May 10, 2001
    US US 85428001 A
  • Priority: May 14, 1999
    US US 31183299 A
  • Priority: Dec 23, 1998
    US US 11362198 P
  • Priority: May 15, 1998
    US US 8557998 P

Download Citation


Sign in to the Lens

Feedback